Funahashi, Y., Okamoto, K., Adachi, Y., Semba, T., Uesugi, M., Ozawa, Y., . . . Oda, Y. (2014). Eribulin mesylate reduces tumor microenvironment abnormality by vascular remodeling in preclinical human breast cancer models. Cancer Sci.
Trích dẫn kiểu ChicagoFunahashi, Yasuhiro, et al. "Eribulin Mesylate Reduces Tumor Microenvironment Abnormality By Vascular Remodeling in Preclinical Human Breast Cancer Models." Cancer Sci 2014.
Trích dẫn MLAFunahashi, Yasuhiro, et al. "Eribulin Mesylate Reduces Tumor Microenvironment Abnormality By Vascular Remodeling in Preclinical Human Breast Cancer Models." Cancer Sci 2014.
Cảnh báo: Các trích dẫn này có thể không phải lúc nào cũng chính xác 100%.